XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation Plans (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Compensation Plans  
Schedule of company's stock option activity

Weighted

Weighted

Average

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

    

Shares

    

Price

    

Term (Years)

    

Value*

Outstanding at December 31, 2022

 

1,345,369

$

25.83

 

  

 

  

Granted

 

 

  

 

  

Exercised

 

(2,100)

18.00

 

  

 

  

Forfeited or expired

 

(1,020)

29.65

 

  

 

  

Outstanding at March 31, 2023

 

1,342,249

$

25.84

 

5.0

$

1,759,000

Exercisable at March 31, 2023

 

889,013

$

26.37

 

3.4

$

780,000

*The aggregate intrinsic value of outstanding and exercisable stock options is defined as the difference between the market value of our Company’s  common stock on March 31, 2023 of $25.30 and the exercise price multiplied by the number of in-the-money outstanding and exercisable stock options.

Schedule of company's restricted stock award

Weighted

Weighted

Average

Shares of

Average

Remaining

Aggregate

Restricted

Grant Date

Contractual

Intrinsic

    

Stock

    

Fair Value

    

Term (Years)

    

Value*

Non-vested at December 31, 2022

 

71,808

$

24.67

 

  

 

  

Issued

 

 

  

 

  

Vested

 

(150)

 

28.77

 

  

 

  

Forfeited

 

-

 

 

  

 

  

Non-vested at March 31, 2023

 

71,658

$

24.66

 

2.4

$

1,813,000

*The aggregate intrinsic value of non-vested restricted stock was calculated using the market value of our Company’s common stock on March 31, 2023 of $25.30 multiplied by the number of non-vested restricted shares outstanding.